These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 21964832

  • 1. Effect of berberine on p53 expression by TPA in breast cancer cells.
    Kim S, Han J, Kim NY, Lee SK, Cho DH, Choi MY, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE.
    Oncol Rep; 2012 Jan; 27(1):210-5. PubMed ID: 21964832
    [Abstract] [Full Text] [Related]

  • 2. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
    Han J, Kim S, Yang JH, Nam SJ, Lee JE.
    Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
    [Abstract] [Full Text] [Related]

  • 3. Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells.
    Kim S, Han J, Lee SK, Choi MY, Kim J, Lee J, Jung SP, Kim JS, Kim JH, Choe JH, Lee JE, Nam SJ.
    J Surg Res; 2012 Jul; 176(1):e21-9. PubMed ID: 22381172
    [Abstract] [Full Text] [Related]

  • 4. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins.
    Lee SJ, Noh HJ, Sung EG, Song IH, Kim JY, Kwon TK, Lee TJ.
    Int J Oncol; 2011 Feb; 38(2):485-92. PubMed ID: 21170508
    [Abstract] [Full Text] [Related]

  • 5. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK, Meeran SM, Katiyar N, Akhtar S.
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [Abstract] [Full Text] [Related]

  • 6. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC, Zhang T, Lee LH, Shen S.
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [Abstract] [Full Text] [Related]

  • 7. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y, Wu J, Stancel GM, Hyder SM.
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [Abstract] [Full Text] [Related]

  • 8. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA, Christopherson KW, Bhat-Nakshatri P, Goulet RJ, Broxmeyer HE, Kopelovich L, Nakshatri H.
    Oncogene; 2007 May 17; 26(23):3329-37. PubMed ID: 17130833
    [Abstract] [Full Text] [Related]

  • 9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 17; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 10. Berberine suppresses TPA-induced fibronectin expression through the inhibition of VEGF secretion in breast cancer cells.
    Kim S, Oh SJ, Lee J, Han J, Jeon M, Jung T, Lee SK, Bae SY, Kim J, Gil WH, Kim SW, Lee JE, Nam SJ.
    Cell Physiol Biochem; 2013 Mar 17; 32(5):1541-50. PubMed ID: 24335179
    [Abstract] [Full Text] [Related]

  • 11. The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M.
    Liu J, Li C, Ahlborn TE, Spence MJ, Meng L, Boxer LM.
    Cell Growth Differ; 1999 Oct 17; 10(10):677-83. PubMed ID: 10547071
    [Abstract] [Full Text] [Related]

  • 12. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825
    [Abstract] [Full Text] [Related]

  • 13. Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.
    Kim S, Choi JH, Lim HI, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.
    Phytomedicine; 2009 Jun 15; 16(6-7):573-80. PubMed ID: 19181503
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells.
    Gehrau RC, D'Astolfo DS, Andreoli V, Bocco JL, Koritschoner NP.
    Mutat Res; 2011 Feb 10; 707(1-2):15-23. PubMed ID: 21147133
    [Abstract] [Full Text] [Related]

  • 15. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.
    Cell Biochem Biophys; 2009 Feb 10; 55(2):95-105. PubMed ID: 19593673
    [Abstract] [Full Text] [Related]

  • 16. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA, Lupu R.
    Int J Mol Med; 2005 Jan 10; 15(1):33-40. PubMed ID: 15583825
    [Abstract] [Full Text] [Related]

  • 17. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
    Tian B, Liu J, Liu B, Dong Y, Liu J, Song Y, Sun Z.
    J Cell Physiol; 2011 Dec 10; 226(12):3433-41. PubMed ID: 21344396
    [Abstract] [Full Text] [Related]

  • 18. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.
    Mol Carcinog; 2006 Jan 10; 45(1):26-37. PubMed ID: 16267831
    [Abstract] [Full Text] [Related]

  • 19. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.
    Chen CS, Lee CH, Hsieh CD, Ho CT, Pan MH, Huang CS, Tu SH, Wang YJ, Chen LC, Chang YJ, Wei PL, Yang YY, Wu CH, Ho YS.
    Breast Cancer Res Treat; 2011 Jan 10; 125(1):73-87. PubMed ID: 20229177
    [Abstract] [Full Text] [Related]

  • 20. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 10; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.